BACKGROUND: Chronic pain is a frequent post-operative complication, affecting~20-40% of patients who have undergone surgery of the female genital or alimentary tract. Chronic pain is an important risk factor for diminished quality of life after surgery. Adhesions are frequently associated with chronic post-operative pain; however, surgical treatment of adhesion-related pain is controversial. SEARCH METHODS: A search was conducted using PubMed, EMBASE and CENTRAL, without restrictions pertaining to date, publication status or language. Randomized trials and cohort studies from all surgical interventions for chronic post-operative pain were considered eligible. Patients with a concomitant diagnosis that could cause chronic pain (e.g. endometriosis or inflammatory conditions) were excluded. Outcome measures were graded according to clinical relevance, with improvement of pain at long-term follow-up regarded as most clinically relevant.
BACKGROUND: Chronic pain is a frequent post-operative complication, affecting~20-40% of patients who have undergone surgery of the female genital or alimentary tract. Chronic pain is an important risk factor for diminished quality of life after surgery. Adhesions are frequently associated with chronic post-operative pain; however, surgical treatment of adhesion-related pain is controversial.
Introduction
Chronic abdominal and pelvic pain diminish quality of life in millions of patients, with particularly high disease burden being among women. The prevalence of chronic pelvic pain in women is estimated to be between 5 and 25% (Latthe et al., 2006; Ahangari, 2014) , with treatment costs estimated at £158 million annually in the UK (Daniels and Khan, 2010) . Previous surgery is a predominant cause of chronic abdominal or pelvic pain; incidence of chronic pain following surgery of the female genital or digestive tract is estimated at 20-40% (Sperber et al., 2008; van der Wal et al., 2011; Ten Broek et al., 2013a) . Chronic pain is one of the main risk factors for decreased quality of life after surgery (Bruce and Krukowski, 2006) .
Multiple studies have found post-operative adhesions to be the primary pathological finding in chronic abdominal and pelvic pain. Adhesions are the sole pathological finding in 60% of cases of chronic post-operative pain, and in 45% of pelvic pain cases (Howard et al., 2000; Ten Broek et al., 2013a) . Further, a body of evidence exists supporting a causal relationship between adhesions and chronic pain. Chronic pain has been found to develop following elective gynaecological surgery for non-painful conditions, without relation to irritable bowel syndrome (Sperber et al., 2008) . Adhesion barriers have been shown to reduce functional abdominal complaints, including pain, at long-term follow-up (van der Wal et al., 2011) . Touching of adhesions has been found to precipitate pain in a pain-mapping experiment in conscious women (Howard et al., 2000; Demco, 2004) , consistent with findings that nerve fibres capable of processing pain stimuli exist within adhesions (Sulaiman et al., 2001) . Reformation of adhesions has been linked to relapse of pain after adhesiolysis (Steege, 1994; Nezhat et al., 2000) . Nonetheless, many physicians continue to reject the notion of the causality of adhesions in development of chronic pain.
While substantial evidence links adhesions and chronic pelvic pain, studies of adhesiolysis in the setting of post-operative chronic abdominal pain have yielded mixed results. Initial studies reported symptomatic improvement in greater than 80% of patients who underwent adhesiolysis (Fayez and Clark, 1994; Hallfeldt et al., 1995) . However, in a high-quality randomized trial with long-term follow-up, while 56% of patients reported improvement of pain at 1 year of follow-up after laparoscopic adhesiolysis, this represented a non-significant difference from the 42% improvement seen in the diagnostic laparoscopy control group (Swank et al., 2003) . The study authors explained these results by attributing a placebo effect to the invasiveness of the control procedure (Kaptchuk et al., 2000; Swank et al., 2003) . An alternative explanation is that filmy adhesions were disrupted by the pneumoperitoneum and handling of the tissue for inspection. Such filmy adhesions attached to the parietal peritoneum, or to organs such as the bladder and uterus, were the most painful in the conscious pain-mapping experiment of Demco et al. (Demco, 2004) . It is also notable that this study did not make use of adhesion barriers to control for reformation of adhesions following adhesiolysis. Now, more than a decade after the landmark trial of Swank et al., recent advances in the diagnosis and treatment of adhesionrelated chronic pain hold the potential to improve the management of this debilitating condition (Ten Broek et al., 2016) . Non-invasive diagnosis and mapping of adhesions is now possible with the use of novel imaging techniques such as cine-MRI (Lienemann et al., 2000; Randall et al., 2016) . Additionally, there is mounting evidence concerning the efficacy of adhesion barriers in preventing adhesion formation and reformation (Ten Broek et al., 2014a) . These improvements in practice are complimented by an improved understanding of pain processing and sensitization in chronic visceral pain disorders (Bouwense et al., 2013) .
Despite these recent advancements, the overall efficacy of adhesiolysis in patients with chronic pain attributable to adhesions remains a topic of considerable debate. It is additionally unclear whether adhesiolysis results can be improved through the use of adhesion barriers and new diagnostic imaging techniques (Ten Broek et al., 2014a . The purpose of this systematic review is to investigate the efficacy and harms of adhesiolysis with or without use of an adhesion barrier for treatment of chronic post-operative pain attributable to adhesions. Secondarily, we assess the dissemination of new insights in clinical practice concerning the diagnosis and treatment of adhesionrelated pain.
Methods
This systematic review focused on randomized trials and cohort studies evaluating patients with adhesion-related chronic post-operative pain, who were treated by adhesiolysis with or without use of an adhesion barrier. Inclusion criteria were pain and adhesions from prior surgery, chronic pain of at least 3 months' duration, and a minimum follow-up interval of 3 months. Exclusion criteria were patients with a concomitant diagnosis and studies not presenting original data. Studies that included patients with adhesions from different aetiologies (e.g. endometriosis and inflammatory disease) were considered eligible only if data from the subgroup of patients with post-operative adhesions could be extracted separately. The full review protocol was registered with PROSPERO under registration number CRD 42015024902. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in reporting the results.
Search
Searches included the following MeSH descriptors: 'abdominal pain', 'chronic pain', 'laparotomy', 'laparoscopy', 'abdomen/surgery', 'postoperative complications', 'tissue adhesions', 'pain, postoperative'. Searches were performed in PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL). A detailed description of our search technique can be found in Supplementary Table 1 . No language or date restrictions were applied. The search was performed in March 2016. Reference lists of identified trials were additionally searched to identify additional trials, including those published in 'grey' literature. Supplemental searches were performed to find relevant grey literature and unpublished trials (Supplementary Table 1 ).
Risk of systematic error (bias)
The risk of systematic error was assessed in all analysed studies using the Cochrane Collaboration's tool for bias risk assessment (Higgins and Green, 2011) . Six components associated with a risk of bias were evaluated: generation of the allocation sequence, allocation concealment, blinding of outcome assessors, selective outcome reporting, incomplete follow-up and other potential sources of bias. Studies with a low risk for all six bias components were designated as 'low risk of bias studies'. Studies in which one or more of the six bias components were assessed as being unclear or as having high risk of bias were defined to be 'high risk of bias studies'. Since blinding the surgeon is impossible, surgical studies that applied blinding to patients and outcome assessors were considered to have a low risk of bias in the blinding domain.
Data extraction
Two reviewers independently extracted and checked the data. For relevant articles, we extracted information on study design, including the use of non-invasive techniques for diagnosis of adhesions, use of adhesion barriers, characteristics, number of participants and outcomes reported. Outcome measures extracted from the literature were graded according to clinical relevance ('critical for decision-making', 'important for decision-making' or 'of limited importance') as suggested by the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) working group (Guyatt et al., 2008) . Efficacy outcomes defined as 'critical for decisionmaking' were improvement of pain at long-term follow-up (1 year or longer), and improved quality of life measured by a validated score at long-term follow-up (1 year or longer). Efficacy outcomes graded as 'important for decision-making' were improvement of pain at any follow-up (3 months or longer), improved quality of life at any follow-up (3 months or longer), pain scores at any follow-up (3 months or longer) and return to daily activity or work. The efficacy outcome 'of limited importance' was patients' recommendation of treatment to others.
Harm outcomes defined as 'critical for decision-making' were mortality, bowel injuries, complications resulting in life-threatening situations, ICU admission, reoperation and permanent disability. Harm outcomes defined as 'important for decision-making' were overall incidence of complications and negative diagnostic laparoscopy.
When outcome measures were registered during several time intervals within the same study, we used the data from the longest follow-up period.
Data analysis
We used the inverse variance method of pooling prevalence and continuous data. The Mantel-Haenszel method was applied for the pooling of dichotomous data, with results presented as the relative risk (RR) with 95% CI. A P-value of <0.05 was considered to be statistically significant. Heterogeneity was explored using I 2 tests, as recommended by the Cochrane Handbook for Systematic Reviews of Intervention. An I 2 value between 50 and 75% was defined as substantial heterogeneity, and an I 2 value of 75% or greater was defined as considerable heterogeneity. A fixed-effects model was applied for the meta-analysis. In the presence of significant statistical heterogeneity, a random-effects model was used. Subgroups analyses were made for the type of intervention (adhesion barriers vs. no adhesion barrier), study type (randomized trial vs. cohort), quality of study (low risk of bias vs. high risk of bias), setting (general surgery vs. gynaecology), population (female patients vs. mixed cohort) and location of pain (pelvic pain vs. other or mixed). Data were analysed using Review Manager 5.0 (RevMan; Version 5.1; The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, 2011) and R version 2.12.0.
Results

Search results
Figure 1 depicts the number of studies identified, reviewed and selected, as well as the reasons for exclusion. A total of 4294 unique citations were retrieved, of which 91 were considered to be potentially eligible. After full-text review, 78 papers were excluded. Thus, a total of 13 studies involving 533 patients were included for analysis. adhesion barriers (Swank et al., 2003; Cheong et al., 2014a) . In all studies, adhesiolysis was performed through laparoscopy. Adhesion barriers were used in three studies (Nezhat et al., 2000; Khaitan et al., 2003; Cheong et al., 2014a) . In 10 studies, no adhesion barriers were applied. In three of the studies without adhesion barrier (30%), other techniques were applied with the intention to reduce adhesion reformation. These other techniques were fixation of the uterus in one study, and installation of Ringer's lactate in one study (Goldstein et al., 1979; Fayez and Clark, 1994) . The third study employed a more complex method to prevent reformation, with performance of interval outpatient laparoscopies through Tenckhoff catheters that were left in place between procedures, and through which Ringer's lactate was also infused (Steege, 1994) .
The pre-treatment diagnosis of adhesions was generally made based on a history of previous surgery followed by physical examination, and occasional imaging studies to rule out alternative diagnoses. One study only included patients with documented adhesions by a previous intervention (Steege, 1994) . In the two randomized trials, randomization was performed after confirmation of adhesions by diagnostic laparoscopy (Swank et al., 2003; Cheong et al., 2014a) . None of the identified studies employed non-invasive techniques for diagnosing adhesions, such as visceral slide on ultrasound or cine-MRI, as part of the work-up for patients.
In five papers, all included patients were female (Arndt and Creutzfeldt, 1976; Goldstein et al., 1979; Steege and Stout, 1991; Fayez and Clark, 1994; Nezhat et al., 2000; Cheong et al., 2014a) . The studies with mixed populations also had a strong female predominance, with the percentage of women near 90% (Table I ). The location of pain was pelvic in four studies (Goldstein et al., 1979; Steege and Stout, 1991; Nezhat et al., 2000; Cheong et al., 2014a) . In most studies, the exact location was not reported; cohorts often seemed to be a mix of patients with pain in pelvic area and patients with pain in other abdominal quadrants. In both the gynaecological and general surgery studies, the majority of patients had a mixed history of both previous gynaecological and general surgery interventions (Fayez and Clark, 1994; Hallfeldt et al., 1995; Nezhat et al., 2000; Khaitan et al., 2003; Swank et al., 2003; Dunker et al., 2004) .
Results for the risk of bias assessment are presented in Table II . Only one of the randomized trials had a low risk of bias (Swank et al., 2003) .
Results of adhesiolysis without adhesion barrier
Results of our full analysis are summarized in Table III . One trial randomized between adhesiolysis without adhesion barrier or diagnostic laparoscopy (Swank et al., 2003) . At long-term follow-up of 1 year, improvement of pain was reported in 55.8% of patients in the adhesiolysis group and 41.7% of patients in the control group. The difference between these groups was not significant (RR 1.34; 95% CI: 0.89-2.02; Fig. 2 ). Difference in quality of life (measured by Short Form (SF)-36 pain domain) was also not significant, with a mean difference of 1.30 (95% CI: −7.71-10.31). Also pain scores did not significantly differ (mean difference: −1.60; 95% CI: −11.44-8.24). Return to daily activity and recommendation of treatment were not reported.
There was no mortality reported in this trial. Two bowel perforations occurred in the adhesiolysis group compared with none in the diagnostic laparoscopy group (RR 4.62; 95% CI: 0.23-93.9). Overall six complications were registered in five patients, all in the adhesiolysis group (RR 10.2; 95% CI: 0.58-179.2). The incidence of negative diagnostic laparoscopies was 8% (95% CI: 3-13%).
In addition to the trial detailed above, eight non-comparative cohorts of adhesiolysis without adhesion barrier were identified (Arndt and Creutzfeldt, 1976; Goldstein et al., 1979; Tschudi et al., 1993; Fayez and Clark, 1994; Steege, 1994; Hallfeldt et al., 1995; Bremers et al., 2000; Dunker et al., 2004) . With respect to outcomes 'critical' for decision-making, five studies reported improvement of pain at long-term follow-up. The pooled incidence of long-term improvement was 68% (95% CI: 48-88%) in 249 patients. Quality of life at longterm follow-up, measured with the Gastro-intestinal Quality of Life Index (GIQLI) score (ranging from 0 to 144), was 92.7 (95% CI: 47.7-137.7) in four patients; using the overall SF-36 (ranging from 0 to 100) the score was 53.2 (95% CI: 31.2-75.3) in 52 patients; using only the pain domain from the SF-36 pain, the score was 51 (95% CI: 44.5-57.5).
Regarding outcomes 'important' for decision-making, improvement of pain at any follow-up was 74% (95% CI: 60-88%) in pooled analyses of nine studies comprising 291 patients (Fig. 3) . Pain scores were also significantly decreased compared with baseline following laparoscopic adhesiolysis (Table III) . One study reported return to daily activities in all 156 patients. On outcomes of 'limited' importance, one study reported that 69% (95% CI: 46-91%) of patients would recommend laparoscopic adhesiolysis to other patients with chronic pain.
Regarding harm outcomes 'critical' for decision-making, five studies reported no peri-operative mortality. A total of three bowel injuries occurred in 307 patients who underwent adhesiolysis or diagnostic laparoscopy. For harm outcomes 'important' for decision-making, the incidence of complications following laparoscopic adhesiolysis was 3% (95% CI: 0-6%). The incidence of negative laparoscopy was 16% (95% CI: 6-26%).
Results of adhesiolysis with adhesion barrier
There was one trial, randomizing between adhesiolysis with adhesion barrier and diagnostic laparoscopy (Cheong et al., 2014a) . Follow-up in this trial was limited to 6 months, thus no benefit outcomes graded 'critical' for decision-making were reported. Pain had improved in 61.5% of patients undergoing adhesiolysis at 6 months of follow-up compared with 26.7% in the control group. The difference was not significant, RR 2.31 (95% CI 0.90-5.92; Fig. 2 ). SF-12 pain domain scores at follow-up were significantly better in the group treated by laparoscopic adhesiolysis, with a mean difference of 26.2 (5.93-46.47). The SF-12 emotional domain did not differ significantly between groups (mean difference 6.00; −13.12-25.12). Pain scores, as measured by Visual Analogue Score (VAS), did not significantly differ between laparoscopic adhesiolysis with an adhesion barrier and diagnostic laparoscopy (mean difference: −8.2; 95% CI: −22.19-11.79).
Regarding the 'harm' outcomes, there was no mortality and no bowel injuries reported in this trial. There were also no other complications. The incidence of negative diagnostic laparoscopies was 36% (95% CI: 25-47%). Two additional non-randomized studies reported on the efficacy of adhesiolysis with an adhesion barrier (Nezhat et al., 2000; Khaitan et al., 2003) . Long-term improvement was reported in 67% (95% CI: 49-84%) of 27 patients in one study. Long-term quality of life was not reported. In three studies evaluating adhesiolysis without a barrier, improvement at any follow-up was reported in 66% (95% CI: 56-75%) of 59 patients (Fig. 3) . Quality of life and pain scores were only reported in the trial of Cheong et al. as described above. Return to daily activity and recommendation of treatment were not reported.
Regarding harm outcomes 'critical' for decision-making, three studies reported no peri-operative mortality. A total of four bowel injuries occurred in 117 patients who underwent adhesiolysis or diagnostic laparoscopy. Further, Nezhat reported that two patients who returned for repeat adhesiolysis sustained a bowel injury during the reoperation (Nezhat et al., 2000) . Enterocutaneous fistula, an additional severe complication, was reported in two patients (Khaitan et al., 2003) . For harm outcomes 'important' for decision-making, the incidence of complications following laparoscopic adhesiolysis was 6% (95% CI: 0-11%). The incidence of negative laparoscopy was 36% (95% CI: 25-47%).
Subgroup analysis
The incidence of negative laparoscopies was significantly higher in gynaecological studies compared with general surgery studies: 31% (95% CI: 18-44%) vs. 8% (95% CI: 3-12%) or when comparing cohorts with pelvic pain with cohorts of mixed or abdominal pain: 37% (95% CI: 28-47%) vs. 12 % (95% CI: 3-21%) ( Supplementary Figs 1 and 2) . The incidence of bowel injuries and complications was higher in general surgery studies compared with gynaecological studies, although the difference was not significant (bowel injury, 2% [95% CI: 0-5%] vs. 1% [95% CI: 0-2%] ( Supplementary Fig. 3) ; complications, 6% [95% CI: 2-10%] vs. 2% [95% CI: 0-5%] ( Supplementary Fig. 4) ). Further subgroup analyses yielded no clinically relevant differences.
Discussion
Summary of evidence
Laparoscopic adhesiolysis reduces chronic post-operative pain iñ 70% of patients at a follow-up of any length, and significantly reduces VASs. However, the currently available evidence of long-term efficacy is insufficient and the results from randomized trials are equivocal. The only high-quality randomized trial conducted thus far found no difference in improvement of pain when comparing between patients who underwent laparoscopic adhesiolysis and those who received diagnostic laparoscopy. Morbidity from complications of adhesiolysis occurred in 4% of patients, with no reported mortality. New techniques for non-invasive diagnosis of adhesions have not been applied in any studies thus far, and adhesion barriers have only been used in a distinct minority of patients.
Strengths and limitations of the review
The present study is the first systematic review dedicated to treatment of chronic pain secondary to post-operative adhesions. We included both cohorts of gynaecological surgery and cohorts in which all patients were female, as well as general surgery cohorts with a mixture of female and male patients. Further, we also included cohorts dedicated only to patients with pelvic pain as well as cohorts that included patients with pain in other quadrants of the abdomen. We deliberately included these different cohorts, because we believe peritoneal adhesions should be considered and managed as a single entity whether occurring in the pelvis or in other parts of the abdomen. The mixed cohorts comprised 90% female patients. The few male patients seem to have little impact on the overall results of our analysis. Results in the various subgroup analyses were comparable, indicating that adhesion-related pain indeed responds equally effective to adhesiolysis whether located in the pelvis or elsewhere in the abdomen. The only difference in gynaecological cohorts and cohorts dedicated to pelvic pain on the one hand and the 1 study-78 patients (LA+): 36% (25-47%) 6 studies-368 patients (LA−): 16% (6-26%)
LA, laparoscopic adhesiolysis; LA+, laparoscopic adhesiolysis with adhesion barrier; LA−, laparoscopic adhesiolysis without adhesion barrier; DL, diagnostic laparoscopy; RR, risk ratio; MD, mean difference.
mixed cohorts on the other hand was the higher incidence of negative laparoscopies. These findings probably represent differences in patient selection; patients in the general surgery cohorts often had extensive surgical histories with multiple laparotomies. Another explanation might be that gynaecological patients with pelvic pain have a more extensive differential diagnosis of chronic pain. Unfortunately, a subgroup analyses of men and women was not possible. Because men have a less complex differential diagnosis of chronic pain, causality between adhesions and pain might be more evident. We systematically analysed outcomes related to both benefit and harm, and graded for clinical relevance. Relatively few data are available for the outcomes deemed to be critical for decision-making (improvement of pain and quality of life at long-term follow-up). There were two trials identified, only one of which had a low risk of bias and long-term follow-up (Swank et al., 2003) .
The trial of Cheong et al. (2014a) had a potential source of bias from premature termination of the trial. The trial was prematurely ended because funding for the study stopped after a relatively slow recruitment process (Cheong et al., 2014a) . Reasons for this slow recruitment were not further specified. A potential reason may be the high rate of negative laparoscopies (36%) in the study, causing a large number of patients to be excluded at a late stage of the trial after use of scarce resources such as operating room time. Another reason might be scepticism of referring physicians towards adhesiolysis, resulting in a relatively low referral rate of potential candidates for the trial (Swank et al., 2003; Meuleman et al., 2013; Cheong et al., 2014a) .
Most studies did not report on the prevalence of chronic pain at the index operation. If chronic pain was present prior to the index operation causing the adhesions, chronic pain sensitization rather than the adhesions might have caused chronic pain (Bouwense et al., 2013) . The data presentation did not allow subgroup analysis of the efficacy of adhesiolysis in patients with prior chronic pain. Nevertheless, the trial of Cheong et al. (2014a) showed positive effect of adhesiolysis despite a relative high number of patients with prior chronic pain (40%). No firm conclusions could be drawn regarding the impact of new developments in the field of adhesion treatment, such as non-invasive imaging modalities for diagnosis and use of adhesion barriers. Noninvasive imaging was not applied in the work-up of patients with chronic pain. Only three studies applied an adhesion barrier following adhesiolysis for pain, one of which evaluated results beyond 6 months (Nezhat et al., 2000; Khaitan et al., 2003; Cheong et al., 2014a) .
Comparison with previous research
We deliberately limited the scope of this review to post-operative adhesions. Adhesions in patients without previous surgery are often the result of inflammatory conditions, endometriosis or adenomyosis, all of which with purportedly different pain mechanisms (Wiseman, 2008; Fortin et al., 2015) . Studies that included patients without a history of surgery tended to have higher incidences of negative laparoscopy for adhesions and lower overall success rates. Hebbar et al. found pelvic adhesions in only 20.9% of patients with chronic pelvic pain (Hebbar and Chawla, 2005) . In a trial by Peters et al. (1992) , in which only half of the patients had previous surgery, adhesiolysis was effective in only 45.8% of patients-primarily the subset of patients with dense adhesions. Keltz et al. (2006) reported on adhesiolysis in a cohort in which 40% of patients had previous surgery and 60% had endometriosis. No subgroup analysis of patients with previous surgery was performed. In this study, adhesiolysis only had a limited impact on pain in the right lower quadrant. Patients with a history of surgery have a higher a priori chance of finding adhesions at laparoscopy, and might benefit more from operative intervention because of a lower incidence of concomitant/confounding pelvic pathologies. Indeed, patients with endometriosis were excluded in the randomized trials cited in this paper (Swank et al., 2003; Cheong et al., 2014a) .
Even with this selection of patients with history of prior surgery, the results are equivocal. There was a marked difference in the results of the only two randomized trials (Swank et al., 2003) . The long-term results of adhesiolysis without an adhesion barrier in the trial of Swank compared unfavourably with those reported in other studies. In the trial of Swank et al., only 56% of patients had improved of pain, compared with an average of almost 70% in other studies (Swank et al., 2003; Cheong et al., 2014a) . In contrast, positive results were found in the other trial of Cheong et al. after performing adhesiolysis with application of an adhesion barrier (Swank et al., 2003; Cheong et al., 2014a) .
Striking differences between the trial of Cheong et al. and that of Swank et al. are the use of an adhesion barrier and the duration of follow-up (6 months vs. 12 months) (Swank et al., 2003; Cheong et al., 2014a) . Adhesion barriers can reduce adhesion reformation and there is some evidence that adhesion reformation indeed is associated with recurrence of pain (Nezhat et al., 2000; Khaitan et al., 2003) . However, the choice of barrier in the trial of Cheong et al., Icodextrin 4%, is somewhat controversial. Evidence for efficacy in adhesion prevention for this barrier in gynaecological surgery is scarce (Trew et al., 2011; Ahmad et al., 2015; Hindocha et al., 2015) . Icodextrin has been popularized because of its relatively low cost and easy application compared with other commercially available adhesion barriers. Compared with other barriers, it appears to be one of the least efficacious barriers, especially in the setting of adhesion reformation, which is usually more difficult to prevent than de novo adhesions (Ten Broek et al., 2014a; Ahmad et al., 2015) . However, in one trial with adhesion reformation, the use of icodextrin in surgery for adhesive small bowel obstruction reduced the incidence of clinical recurrences (Catena et al., 2012) .
In addition, the follow-up period in Cheong's trial may be too short for a definitive conclusion. There is some debate on the length of follow-up required to assess the efficacy of adhesiolysis. Although reformation of adhesions begins quickly after surgery (and no significant changes in adhesions are expected after a few months of maturation), the follow-up period should also extend beyond the period of time that any placebo effect of surgery could plausibly be expected to interfere with results. It remains uncertain how long the placebo effect of a sham operation for chronic pain can last, but there is evidence that a placebo effect from invasive treatments tends to be significant and have a long duration (Kaptchuk et al., 2000 (Kaptchuk et al., , 2006 Harris, 2016) .
It is not possible to draw firm conclusion from literature on placebo effects of surgery on the follow-up period that is required to evaluate results of adhesiolysis. We judged a period of at least 1 year to be the most appropriate for long-term follow-up. There was little data available on the efficacy of adhesiolysis with an adhesion barrier beyond 1 year. Only Khaitan et al. (2003) , using a carboxy methylcellulose barrier in 19 patients, had a follow-up period of 1 year after adhesiolysis with an adhesion barrier (Khaitan et al., 2003) . In this study, there was no decline in efficacy when comparing between 6 months and 1 year (Khaitan et al., 2003) .
Learning curve and expertize might also impact results of adhesiolysis. Both of the included trials had been performed by research groups with expertize in this area. Prior to the trial, the group of Swank et al. reported on a retrospective case series of 157 adhesiolysis procedures for pain with few complications. Although this report did not meet our strict inclusion criteria, it demonstrates the clinical expertize of this group in this field. In this series, the short-term relief after adhesiolysis was 80%, consistent with the results seen in studies included in this review (Swank et al., 2002) . Additionally, the group of Cheong et al. inarguably has substantial expertize with treatment of chronic pelvic pain (Cheong and William, 2006; Cheong et al., 2014b) .
The aim of adhesiolysis is to improve symptoms and quality of life, not to prolong life. As such, it is important that the decision to perform the procedure be guided by a carefully considered decision-making process. Although the overall incidence of complications associated with the procedure was relative low, a number of serious complications were reported, including inadvertent bowel injury. In the included studies, no mortality was reported. Nevertheless, bowel injuries are fatal in~8% of cases (Swank et al., 2002; Ten Broek et al., 2013a,b) . Although the sample sizes were too small to reach significance, there was a trend towards an increased rate of complications in the general surgery cohorts compared with the gynaecological cohorts. These findings probably represent differences in patient selection: patients in the general surgery cohorts often had extensive surgical histories with multiple laparotomies (Ten Broek et al., 2014b) . With an increasing number of repeat operations, the a priori risk of having denser and more numerous adhesions rises (Strik et al., 2015) . Dense adhesions harbour a higher risk of organ injury upon adhesiolysis.
Implications for future research
Over a decade after the trial conducted by Swank et al., scant progress has been made towards the proper management of chronic abdominal and pelvic pain caused by adhesions. The recent progress made in both the diagnosis and treatment of adhesions suggests that renewed investigation of adhesiolysis may be worthwhile (Ten Broek et al., 2016) . Long-term follow-up was lacking in most included studies. Future studies should obtain long-term results to prevent biases in the results from placebo effects of surgery. More research is needed to also investigate whether non-invasive diagnostic techniques can be used to guide clinical decision-making in patients with pain from adhesions.
Over recent years, non-invasive techniques for diagnosing adhesions using the 'visceral slide' principle have become available (Lienemann et al., 2000; Minaker et al., 2015; Ha et al., 2016; Randall et al., 2016) . Adhesions are not directly visible on imaging with noninvasive diagnosis; however, with movement of the abdominal wall amid increasing intra-abdominal pressure, intra-peritoneal organs should move without restriction. Aberrant movement patterns on dynamic imaging studies could indicate the presence of adhesions. This non-invasive diagnostic tool has shown promise in diagnosing adhesions to the abdominal wall (Lienemann et al., 2000; Kirchhoff et al., 2010; Randall et al., 2016) .
Several adhesions barriers are commercially available, although none seem to have ideal properties for the indication of chronic pain (Schreinemacher et al., 2010; Tsuruta et al., 2015) . Hyaluronic acidcarboxy methylcellulose is the most extensively investigated barrier at present. Although techniques for placing this barrier have been described, most surgeons consider its placement to be inconvenient (Wiseman et al., 1998; Ten Broek et al., 2014a) . Icodextrin 4% solution is more easily placed in laparoscopy, but has low viscosity and is absorbed relatively quickly, which may reduce its efficacy in preventing long-term adhesion reformation (Ten Broek et al., 2014a) .
Development of a next-generation barrier for chronic pain should therefore focus on ease of laparoscopic use and efficacy in adhesion reformation after adhesiolysis. Such barriers needs to be tested for their long-term results.
Implications for clinical practice
Even after selecting only patients with a history of previous surgery, the efficacy of adhesiolysis for chronic pain remains inconclusive. Reasonable concerns regarding long-term efficacy, the relatively high number of negative laparoscopies and the risk of serious inadvertent visceral injuries warrant a restrictive policy towards elective adhesiolysis for chronic pain. More evidence on this topic is needed, especially on novel techniques for diagnosis and prevention of adhesion reformation. To avoid such risks, clinicians should first attempt to control pain by conservative treatments. Unfortunately, evidence for conservative treatment options is similarly lacking. Consequently, chronic abdominal and pelvic pain is a driver of long-term use of analgetics and opioid dependency, and frequently incurs high-cost multidisciplinary or complementary treatments which lack sufficient evidence for efficacy (Cheong et al., 2014b; Volkow and McLellan, 2016) . In a recent Cochrane review of non-surgical interventions for chronic pelvic pain, none of the studies was dedicated to patients with adhesions (Cheong et al., 2014b) . Moreover, the quality of evidence for different pharmacological, psychological, dietary and lifestyle interventions was poor (Cheong et al., 2014a) . Silverman et al. (2012) performed a trial with pregabalin in a cohort of patients with adhesion-related pain, but the study was underpowered. Based on expert opinion, we suggest a 'team approach' to the patient with chronic pain, to target all possible factors that might contribute to pain. Anxiety, for example, is a common feature in patients with chronic pain that may need further attention (Miller-Matero et al., 2016) .
Adhesiolysis should preferably be performed in the setting of clinical studies. Evidence for adhesion barriers in the specific indication of chronic pain is low. Nevertheless, we believe that in cases where operative treatment is considered, there is merit to the application of adhesion barriers, given the increasing evidence for their efficacy in other clinically relevant outcomes (Ten Broek et al., 2014a) . The harms reported in this review relate to the procedure of adhesiolysis itself, rather than to the placement of a barrier.
Conclusion
Laparoscopic adhesiolysis reduces pain from adhesions in~70% of patients in the initial phase after treatment. While the number of reported complications was low, such complications did include severe adverse events such as bowel injuries. Adhesiolysis without application of an adhesion barrier was not efficacious in a trial with long-term follow-up. The long-term efficacy of adhesiolysis with an adhesion barrier is still unclear. No study used novel non-invasive techniques to diagnose adhesions in the work-up phase. At present, there is little evidence to support routine use of adhesiolysis as a treatment for chronic pain. Further research is needed to investigate whether the results of adhesiolysis can be improved by new techniques for diagnosis and prevention of adhesion reformation.
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